Wellorithm vs TMates: 50-State Clinicians vs 24/7 Doctors
Wellorithm vs TMates: which telehealth GLP-1 option fits your needs? Quick verdict: choose Wellorithm if you need both compounded semaglutide and tirzepatide plus licensed clinicians in all 50 states; choose TMates if you prefer a flat $199/month price with 24/7 U.S. doctor access and consistent dosing costs. This article compares the two directly on availability, medication options, pricing model, clinical access, and regulatory notes to help you decide.
Start Wellorithm eligibility quiz
Side-by-side snapshot: Wellorithm vs TMates
| Criteria | Wellorithm | TMates |
|---|---|---|
| Medication options | Compounded semaglutide and tirzepatide available | Compounded semaglutide primarily; limited public tirzepatide detail |
| Clinical coverage | Licensed clinicians in all 50 states | U.S.-based doctors, licensed coverage in all 50 states |
| Pricing model | Starting price listed as $147; full pricing provided after intake quiz | Flat $199/month at every dose, no step-up fees |
| Doctor access | Virtual consultations and ongoing check-ins | 24/7 access to U.S.-based doctors |
| Shipping and fees | Medication shipped to home; promotion language captured as fast, free shipping | Free shipping; cancel anytime language on direct-pay model |
Availability and clinician coverage
Both Wellorithm and TMates report clinician coverage across all 50 states. Wellorithm emphasizes licensed clinicians in all 50 states as a strength for patients in states with limited GLP-1 telehealth options. TMates likewise states licensed U.S.-based doctors in all 50 states with the added claim of 24/7 physician access. The evidence shows both platforms aim for nationwide access, but TMates highlights continuous physician availability.
Check Wellorithm clinician network
Medication offerings and formulation
Wellorithm lists both compounded semaglutide and compounded tirzepatide, while TMates focuses on compounded semaglutide with limited public detail on tirzepatide availability. Wellorithm explicitly offers tirzepatide options in its messaging; TMates emphasizes clinically dosed compounded semaglutide and notes formulation in U.S.-based facilities. If access to tirzepatide is a deciding factor, the supplied evidence supports Wellorithm for that option.
Pricing and billing approach
Pricing is a clear point of contrast. TMates advertises a flat $199/month rate at every dose with no step-up fees, presented as predictable monthly billing. Wellorithm presents starting figures such as $147 and marketing language like starting at $249 for some items, but also states that personalized pricing is provided after completing the intake quiz. The source material notes Wellorithm does not publish full pricing upfront, while TMates publishes a flat per month fee.
See TMates pricing and sign up
Clinical oversight and patient support
TMates emphasizes 24/7 access to U.S.-based doctors and virtual check-ins, positioning itself as clinically supervised with continuous physician availability. Wellorithm uses licensed clinicians and virtual consultations with ongoing check-ins but does not claim around-the-clock physician access in the captured evidence. Both platforms use virtual care and clinician review; TMates highlights higher-frequency access in its materials.
Regulatory and safety notes
Both providers’ evidence includes the same important regulatory qualifier: compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Wellorithm explicitly repeats this regulatory note in its detailed description; TMates also includes the regulatory note in captured content. Treatment and prescriptions are subject to clinician review and medical appropriateness in both cases.
How to choose between Wellorithm and TMates
Wellorithm vs TMates comes down to three main distinctions in the supplied evidence: medication range (Wellorithm includes tirzepatide), pricing transparency (TMates lists a flat $199/month; Wellorithm provides personalized quotes after an intake), and clinical access (TMates highlights 24/7 U.S. doctor availability; Wellorithm emphasizes licensed clinicians in all 50 states).
Conclusion: Wellorithm vs TMates
Wellorithm is best for patients who need both compounded semaglutide and compounded tirzepatide and value a 50-state clinician network. TMates is best for patients who want a predictable flat $199/month price with 24/7 access to U.S.-based doctors and consistent dosing costs. Remember that both use compounded medications that are not FDA-approved and that treatment is available subject to clinician review and medical appropriateness.
Choose Wellorithm if you need compounded tirzepatide or broad 50-state clinician coverage. Choose TMates if you prioritize flat-rate pricing at $199/month and around-the-clock access to U.S.-based doctors.